Back

Dilated cardiomyopathy in Becker muscular dystrophy: therapeutic limits and opportunities in advanced heart failure

9 May 2026 (14:30 - 14:39)
Organised by: Logo
Congress Presentation Part of: When systemic and genetic disease affects the heart Clinical HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Claudia Cestie

Sapienza University of Rome, Rome (Italy)

4 More presentations in this session

Presentation thumbnail
Burning down the powerhouse: raising a red flag
Miss A. Trezza (Milan, IT)
Slides Video
Presentation thumbnail
Early systolic dysfunction in a patient with neuromuscular disease: diagnostic and therapeutic challenges
Doctor R. Esculudes Dos Santos Ferrao Gomes (Lisboa, PT)
Slides Video
Presentation thumbnail
Danon disease presenting with severe rapidly progressive cardiomyopathy in a young paediatric male patient
Doctor R. Esculudes Dos Santos Ferrao Gomes (Lisboa, PT)
Slides Video
Presentation thumbnail
First in-vivo metabolic signature of mitochondrial oxidative failure driving infantile Alstrom-related dilated cardiomyopathy
Doctor A. Guarnaccia (Porto Viro, IT)
Video

Access the full session

Session thumbnail
When systemic and genetic disease affects the heart
Video

The Event

Event poster

Heart Failure 2026

9 May 2026 14:30 CET
You may be interested in
thumbnail
Congress Session
Congestion without a simple answer: from left ventricular hypertrophy clues to shunt solutions
thumbnail
Congress Session
Advanced heart failure: long-term therapeutic opportunities
thumbnail
Congress Session
Clinical Case Award

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources